« "Priorities 2008": Conference of the International Society for Priorities in Health Care | Main | American Public Health Association: 136th Annual Meeting »
October 23, 2008
Enhancing Observational Research to Demonstrate Product Value -- Leveraging patient registries to achieve safety, quality, efficacy & cost-effectiveness outcomes
Location: Vienna, Austria
Dates: 23-24 October, 2008
Venue: Renaissance Hotel-Imperial Riding School
This event will bring together a strong selection of speakers and discover their unique approaches and techniques in order to maximize observational research performance. Together, we will be examining the growing role of non-interventional research in achieving stronger safety results, better cost effectiveness outcomes and higher drug performance.
Speakers include:
- Novartis Vaccines & Diagnostics, USA-Vice President & Head Pharmacovigilance & Medical Safety
- Baxter Innovations, Austria-European Medical Director, Clinical Operations
- Amgen, Austria-Executive Medical Director Eastern Europe
- Sanofi-Aventis, Hungary-Affiliate Pharmacovigilance Head & Regulatory Medical Affairs Manager
- Astellas, UK-Senior Director, Medical Affairs & Health Economics Europe
- UCB Global Medical Safety & Risk Management, Belgium-Safety Physician, Ass. Director
- Biogen Idec, USA-Associate Director, Neurology
- Institute for Quality and Efficiency in Health Care, Germany-Deputy Head of Department Non-drug Interventions
- Medical University of Vienna-Head of Ethics Committee
- BPI, German Pharmaceutical Industry Association-Head of Clinical Research and Pharmacovigilance
- Stiefel Laboratories, UK-VP Global Pharmacovigilance, EU Qualified Person for Pharmacovigilance
and many more …
Together, they will deliver knowledge, expertise, insights, opinions, facts and data that can add strategic intelligence and real-value to your business.
Why attend?
- Find out when to run observational studies, for what purpose, where, what size, how they should be designed.
- Learn how patient and disease registries can be utilized to enhance pharmacovigilance and market access campaigns.
- Hear the real life experiences of those who have successfully performed observational studies and how they overcame significant challenges.
- Discover for yourself what is “best practice” in non-interventional research, by understanding both the strategic & operational perspectives and practical challenges.
To request full agenda please contact Andrea Valent at NextLevel Pharma
andrea@nextlevelpharma.com
Ph: + 421 2 3266 2621
http://www.nextlevelpharma.com/
